<SEC-DOCUMENT>0001326110-23-000076.txt : 20230614
<SEC-HEADER>0001326110-23-000076.hdr.sgml : 20230614
<ACCEPTANCE-DATETIME>20230614171506
ACCESSION NUMBER:		0001326110-23-000076
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230613
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230614
DATE AS OF CHANGE:		20230614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ImmunityBio, Inc.
		CENTRAL INDEX KEY:			0001326110
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				431979754
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37507
		FILM NUMBER:		231015008

	BUSINESS ADDRESS:	
		STREET 1:		3530 JOHN HOPKINS COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(844) 696-5235

	MAIL ADDRESS:	
		STREET 1:		3530 JOHN HOPKINS COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NantKwest, Inc.
		DATE OF NAME CHANGE:	20150713

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Conkwest, Inc.
		DATE OF NAME CHANGE:	20140416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZelleRx Corp
		DATE OF NAME CHANGE:	20050504
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ibrx-20230613.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:dde078f5-98c7-47b5-ab32-a2774d4ecadd,g:827debd4-f8c9-486d-8cad-ec7a2a200e4d,d:d4752247f6e24339af3bbae81c294b27--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ibrx-20230613</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN180L2ZyYWc6OTM0ZTk5MmNhZjhlNDA3N2IzZTc5MDMzYjA2ZWEyZjIvdGFibGU6NzU1MjZmYWQwODc0NDljYmE1MmJjNTk0ZWI0ZmI3YjYvdGFibGVyYW5nZTo3NTUyNmZhZDA4NzQ0OWNiYTUyYmM1OTRlYjRmYjdiNl8wLTEtMS0xLTMzOTY2MQ_de8c0ab4-ddc5-44a5-a99b-821ca7897ad0">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN180L2ZyYWc6OTM0ZTk5MmNhZjhlNDA3N2IzZTc5MDMzYjA2ZWEyZjIvdGFibGU6NzU1MjZmYWQwODc0NDljYmE1MmJjNTk0ZWI0ZmI3YjYvdGFibGVyYW5nZTo3NTUyNmZhZDA4NzQ0OWNiYTUyYmM1OTRlYjRmYjdiNl8xLTEtMS0xLTMzOTY2MQ_8e7fe26d-1fd2-4e21-a53d-52f5e58c33b3">0001326110</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ibrx-20230613.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic573696c5133416983acc6b174855433_D20230613-20230613"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001326110</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-13</xbrli:startDate><xbrli:endDate>2023-06-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id4752247f6e24339af3bbae81c294b27_1"></div><div style="min-height:13.5pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzY5_6c530b40-5c37-4da0-84e1-7e669338456d">8-K</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)of The Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8yMjc_bb0ce066-46ec-4f73-8ffa-ac08eb6f4d2f">June&#160;13,&#160;2023</ix:nonNumeric></span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzcz_446a7a89-a699-469b-b235-1a06f419da16">ImmunityBio, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:31.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.754%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MGYyOGVhYmMyNWExNDg2M2IyMGQzMDBkMjY5OGI1M2UvdGFibGVyYW5nZTowZjI4ZWFiYzI1YTE0ODYzYjIwZDMwMGQyNjk4YjUzZV8wLTAtMS0xLTMzOTY2MQ_0cc12a1b-74b6-47fd-b4a3-6ac302b93acf">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MGYyOGVhYmMyNWExNDg2M2IyMGQzMDBkMjY5OGI1M2UvdGFibGVyYW5nZTowZjI4ZWFiYzI1YTE0ODYzYjIwZDMwMGQyNjk4YjUzZV8wLTItMS0xLTMzOTY2MQ_87b545a6-a0af-4873-967f-b3a895c53d74">001-37507</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MGYyOGVhYmMyNWExNDg2M2IyMGQzMDBkMjY5OGI1M2UvdGFibGVyYW5nZTowZjI4ZWFiYzI1YTE0ODYzYjIwZDMwMGQyNjk4YjUzZV8wLTQtMS0xLTMzOTY2MQ_ea2f983a-4da4-4a96-a2e9-dfb6020483af">43-1979754</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzcw_8d05f952-47ed-4ac3-b856-3dd8bc6c29af">3530 John Hopkins Court</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzc0_17d93e49-9c4e-45a6-8f32-6dd9b1a2d104">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzc1_ca1ee43c-c9bb-472d-81f0-e126b64c28a5">California</ix:nonNumeric> <ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzcy_7da7af64-403c-4505-91c1-dd8ef62b841f">92121</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzcx_9ed94189-5192-481b-a06c-20ff1465aafe">(844)</ix:nonNumeric> <ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzY3_c168ec07-a023-44bf-a1dc-b04f69ee9d67">696-5235</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.827%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction&#160;A.2. below):</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MDg4N2U4ZjUyMmE2NDU4Nzk3NTBjYzZlNjc2ZWMxZTAvdGFibGVyYW5nZTowODg3ZThmNTIyYTY0NTg3OTc1MGNjNmU2NzZlYzFlMF8wLTAtMS0xLTMzOTY2MQ_bd6be309-01f4-4953-9432-828ba93bd145">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MDg4N2U4ZjUyMmE2NDU4Nzk3NTBjYzZlNjc2ZWMxZTAvdGFibGVyYW5nZTowODg3ZThmNTIyYTY0NTg3OTc1MGNjNmU2NzZlYzFlMF8yLTAtMS0xLTMzOTY2MQ_c667dee1-22d9-4d11-a26f-6788c40abc5d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MDg4N2U4ZjUyMmE2NDU4Nzk3NTBjYzZlNjc2ZWMxZTAvdGFibGVyYW5nZTowODg3ZThmNTIyYTY0NTg3OTc1MGNjNmU2NzZlYzFlMF80LTAtMS0xLTMzOTY2MQ_af7f9738-5b0a-455e-b5fe-0044afba8268">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MDg4N2U4ZjUyMmE2NDU4Nzk3NTBjYzZlNjc2ZWMxZTAvdGFibGVyYW5nZTowODg3ZThmNTIyYTY0NTg3OTc1MGNjNmU2NzZlYzFlMF82LTAtMS0xLTMzOTY2MQ_38a898e7-9d24-4b79-85a1-ecb608534cf9">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.419%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Trading</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Name of each exchange</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">on which registered</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6YmQ4ZmRjNzQ5YzRkNGRiNmI5NWQxNGYyMzlmNmM1ZDUvdGFibGVyYW5nZTpiZDhmZGM3NDljNGQ0ZGI2Yjk1ZDE0ZjIzOWY2YzVkNV8xLTAtMS0xLTMzOTY2MQ_1728ef78-1f39-4741-85e3-5e7638db61f4">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6YmQ4ZmRjNzQ5YzRkNGRiNmI5NWQxNGYyMzlmNmM1ZDUvdGFibGVyYW5nZTpiZDhmZGM3NDljNGQ0ZGI2Yjk1ZDE0ZjIzOWY2YzVkNV8xLTItMS0xLTMzOTY2MQ_d58597b0-782f-494d-93a0-6a8377283edb">IBRX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6YmQ4ZmRjNzQ5YzRkNGRiNmI5NWQxNGYyMzlmNmM1ZDUvdGFibGVyYW5nZTpiZDhmZGM3NDljNGQ0ZGI2Yjk1ZDE0ZjIzOWY2YzVkNV8xLTQtMS0xLTMzOTY2MQ_a83e864a-9be1-44b1-862e-24e235ae235b">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of&#160;1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company <ix:nonNumeric contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzY4_329896f0-1120-4de7-9de2-75254321f57b">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id4752247f6e24339af3bbae81c294b27_87"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 1 &#8211; Registrant&#8217;s Business and Operations</span></div><div id="id4752247f6e24339af3bbae81c294b27_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01&#160;&#160;&#160;&#160;Entry into a Material Definitive Agreement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">$30.0 million Variable-Rate Promissory Note</span></div><div style="margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in a Form&#160;8-K filed by ImmunityBio,&#160;Inc. (the &#8220;Company&#8221;) on May&#160;11,&#160;2023, on May&#160;9,&#160;2023, the Company&#8217;s Executive Chairman and Global Chief Scientific and Medical Officer agreed to provide non-convertible debt financing to the Company in an amount of $30.0&#160;million on substantially similar terms as prior financings. To that end, on June&#160;13,&#160;2023, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company executed a $30.0&#160;million promissory note with Nant&#160;Capital, LLC (&#8220;Investor&#8221;), an entity affiliated with Dr.&#160;Patrick Soon-Shiong, our Executive Chairman and Global Chief Scientific and Medical Officer (the &#8220;Note&#8221;). The Company may request up to three&#160;(3) advances of ten&#160;million dollars ($10,000,000) each pursuant to the Note. The principal amount of each advance will bear interest at term secured overnight financing rate (&#8220;Term&#160;SOFR&#8221;) plus 8.0%&#160;per annum. The accrued interest on any advance shall be payable quarterly on the last business day of June, September and December. The outstanding principal amount and any accrued and unpaid interest on advances are due on the earlier of (i)&#160;December&#160;31,&#160;2023 or (ii)&#160;upon the occurrence and during the continuance of an Event of Default (as defined in the Note). We may prepay the outstanding principal amount, together with any accrued interest, on any then-outstanding advances, at any time, in whole or in part, without premium or penalty, and without the prior consent of Investor, upon five&#160;(5) days written notice to Investor.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to receive net proceeds of approximately $29.85&#160;million from this financing, net of a $150,000&#160;origination fee (0.5%)&#160;paid to the Investor, assuming all advances are drawn under the Note, which we intend to use, together with other available funds, to progress our pre-commercialization efforts and clinical development programs, fund other research and development activities, for capital expenditures, and for other general corporate purposes. We may also use a portion of the net proceeds to license intellectual property or to make acquisitions or investments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing is only a brief description of the material terms of the Note, and does not purport to be a complete description of the rights and obligations of the parties thereunder, and is qualified in its entirety by reference to the note that is filed as Exhibit&#160;10.1 to this Current Report on Form&#160;8-K and incorporated herein by reference.</span></div><div id="id4752247f6e24339af3bbae81c294b27_103"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 2 &#8211; Financial Information</span></div><div id="id4752247f6e24339af3bbae81c294b27_109"></div><div style="margin-top:18pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.03&#160;&#160;&#160;&#160;Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent relevant, the information set forth in Item&#160;1.01 above is incorporated by reference into this Item&#160;2.03.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id4752247f6e24339af3bbae81c294b27_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 5 &#8211; Corporate Governance and Management</span></div><div id="id4752247f6e24339af3bbae81c294b27_10"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07&#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;13,&#160;2023, ImmunityBio,&#160;Inc. held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;). Of the 435,923,104&#160;shares of our common stock, par value $0.0001 per share (&#8220;Common Stock&#8221;) outstanding as of April&#160;17,&#160;2023, 374,681,050&#160;shares of Common Stock were represented, either by attending the Annual Meeting virtually or by proxy, constituting (i)&#160;a quorum under the company&#8217;s bylaws and (ii)&#160;approximately 86% of the outstanding shares of Common Stock entitled to vote. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below.</span></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt">Election of Nine&#160;Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The following nominees were re-elected by the holders of our Common Stock to serve as directors for a one&#160;year term expiring at the 2024&#160;annual meeting of stockholders based on the following results of voting. Each director&#8217;s term continues until the election and qualification of his or her successor, or until his or her earlier retirement, resignation, disqualification, removal, or death.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:35.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nominee</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;For&#8221;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;Withheld&#8221;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Broker Non-Votes&#8221;</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick Soon-Shiong, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334,538,179</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,075,920</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheryl L. Cohen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,932,285</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681,814</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard Adcock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,531,860</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082,239</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael D. Blaszyk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,884,168</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729,931</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Owen Brennan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,964,499</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,649,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wesley Clark</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,703,037</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,911,062</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Maxwell, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340,016,716</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597,383</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christobel Selecky</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,831,897</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782,202</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barry J. Simon, M.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,635,450</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978,649</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,066,951</span></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#576566;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt">Ratification of Appointment of Independent Registered Public Accounting Firm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31,&#160;2023 was ratified based on the following results of voting:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;For&#8221;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes &#8220;Against&#8221;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Broker Non-Votes&#8221;</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,132,354</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270,094</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,602</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id4752247f6e24339af3bbae81c294b27_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 9 &#8211; Financial Statements and Exhibits</span></div><div id="id4752247f6e24339af3bbae81c294b27_19"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.326%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ibrx-2023613x8kexhibit101.htm">Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated June 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ibrx-2023613x8kexhibit101.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ibrx-2023613x8kexhibit101.htm">, 2023.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;104</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover page interactive data file (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id4752247f6e24339af3bbae81c294b27_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">IMMUNITYBIO, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: June&#160;14,&#160;2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ David C. Sachs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">David C. Sachs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">Chief Financial Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ibrx-2023613x8kexhibit101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i66fd16c6e8854b2aba86c47dc4155d3f_58"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT 10.1</font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">ACT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THIS NOTE MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. THE ISSUER OF THIS NOTE MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.</font></div><div style="margin-top:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IMMUNITYBIO, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PROMISSORY NOTE</font></div><div style="margin-top:24pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$30,000,000</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">June&#160;13,&#160;2023</font></td></tr></table></div><div style="margin-top:24pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED, ImmunityBio, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) promises to pay to NANT&#160;CAPITAL, LLC or its registered assigns (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Investor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), in lawful money of the United States of America, the principal amount of each advance (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) made by Investor to the Company pursuant to this Promissory Note (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), in immediately available funds, at the times and in the manner set forth herein, together with interest from the date of each Advance on the unpaid principal balance of each Advance at a rate equal to the Term SOFR Rate (as defined below) plus 8.0%&#160;per annum which shall be adjusted to the then current SOFR on each Interest Payment Date, computed on the basis of the actual number of days elapsed and a year of 365&#160;days. All unpaid principal of all Advances under this Note, together with any then unpaid and accrued interest and other amounts payable hereunder, shall be due and payable on the earlier of (i)&#160;December&#160;31,&#160;2023 (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), or (ii)&#160;when, upon the occurrence and during the continuance of an Event of Default, such amounts are declared due and payable by Investor or made automatically due and payable, in each case, in accordance with the terms hereof. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following is a statement of the rights of Investor and the conditions to which this Note is subject, and to which Investor, by the acceptance of this Note, agrees&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Advances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may request up to three (3) Advances of Ten Million Dollars ($10,000,000) each pursuant to this Note. The principal amount of each Advance made by Investor to the Company hereunder, the date on which each such Advance is made, the amount of any prepayment or partial prepayment of any such Advance, and the outstanding principal amount of each such Advance, shall be recorded in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> attached hereto. The Company shall be entitled to update </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereto from time to time to reflect updated information relating to the Advances made by Investor to the Company hereunder and any prepayments or partial prepayments by the Company of the outstanding principal amounts of any such Advances. The information reflected in any such updated version of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> delivered by the Company to Investor shall, in the absence of manifest error, constitute </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">prima facie </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">evidence of the accuracy of the information recorded, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that the failure of the Company to update the information specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in connection with the making by Investor to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Company of any Advance or the payment or partial prepayment by the Company of any such Advance shall not affect the obligations of the Company hereunder to repay the outstanding principal amount of any such Advance (and any accrued but unpaid interest thereon) in accordance with the terms of this Note.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27.75pt">Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.8pt">Interest. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accrued interest on each Advance shall be payable quarterly, in arrears, on each Interest Payment Date.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.18pt">Voluntary Prepayment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Upon five business days&#8217; prior written notice to Investor, the Company may prepay any of the then-outstanding Advances under this Note in whole or in part, without premium or penalty and without the prior consent of Investor, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such prepayment will be applied first to the payment of accrued but unpaid interest on such Advance and second, if the amount of prepayment exceeds the amount of all such interest, to the payment of outstanding principal of the respective Advance.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27.75pt">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The occurrence of any of the following shall constitute an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; under this Note. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.8pt">Failure to Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall fail to pay the principal of, plus any accrued and unpaid interest on, this Note on the Maturity Date&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.18pt">Voluntary Bankruptcy or Insolvency Proceedings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company shall (i)&#160;apply for or consent to the appointment of a receiver, trustee, liquidator or custodian of itself or of all or a substantial part of its property, (ii)&#160;admit in writing its inability to pay its debts generally as they mature, (iii)&#160;make a general assignment for the benefit of its or any of its creditors, (iv)&#160;be dissolved or liquidated, (v)&#160;commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to itself or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or consent to any such relief or to the appointment of or taking possession of its property by any official in an involuntary case or other proceeding commenced against it, or (vi)&#160;take any action for the purpose of effecting any of the foregoing&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.8pt">Involuntary Bankruptcy or Insolvency Proceedings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Proceedings for the appointment of a receiver, trustee, liquidator or custodian of the Company, or of all or a substantial part of the property thereof, or an involuntary case or other proceedings seeking liquidation, reorganization or other relief with respect to the Company or any of its subsidiaries, if any, or the debts thereof under any bankruptcy, insolvency or other similar law now or hereafter in effect shall be commenced and an order for relief entered or such proceeding shall not be dismissed or discharged within 45&#160;days of commencement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27.75pt">Rights of Investor upon Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Upon the occurrence of any Event of Default (other than an Event of Default described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section&#160;3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and at any time thereafter during the continuance of such Event of Default, Investor may, by written notice to the Company, declare all outstanding Obligations payable by the Company hereunder to be immediately due and payable without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived, anything contained herein to the contrary notwithstanding. Upon the occurrence of any Event of Default described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section&#160;3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, immediately and without notice, all outstanding Obligations payable by the Company hereunder shall automatically become immediately due and payable, without presentment, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">demand, protest or any other notice of any kind, all of which are hereby expressly waived, anything contained herein to the contrary notwithstanding. In addition to the foregoing remedies, upon the occurrence and during the continuance of any Event of Default, Investor may exercise any other right, power or remedy otherwise permitted to it by law, either by suit in equity or by action at law, or both.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27.75pt">Representations and Warranties of Investor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By acceptance of this Note, Investor represents and warrants to the Company that Investor has full legal capacity, power and authority to execute and deliver this Note and to perform its obligations hereunder. This Note constitutes valid and binding obligations of Investor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors&#8217; rights generally and general principles of equity.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27.75pt">Origination Fee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In connection with, and upon the funding of each Advance, the Company shall pay to Investor an origination fee of one-half of one&#160;percent (0.5%) of each such Advance.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27.75pt">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As used in this Note, the following capitalized terms have the following meanings&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">CME Term SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means CME Group Benchmark Administration Limited as administrator of the forward-looking term Secured Overnight Financing Rate (SOFR) (or a successor administrator).</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning given in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section&#160;3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereof.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Investor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the Person specified in the introductory paragraph of this Note or any Person who shall at the time be the registered holder of this Note. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Interest Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the last business day of each of June, September and December.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, for each Advance (a)&#160;the period commencing on the date of such Advance and ending on the first Interest Payment Date immediately following such date and (b)&#160;each three-month period thereafter ending on an Interest Payment Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that (i)&#160;if any Interest Period would end on a day other than a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless such next succeeding Business Day would fall in the next calendar month, in which case such Interest Period shall end on the next preceding Business Day, and (ii)&#160;any Interest Period that commences on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the last calendar month of such Interest Period) shall end on the last Business Day of the last calendar month of such Interest Period.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean and include all loans, advances, debts, liabilities and obligations, howsoever arising, owed by the Company to Investor of every kind and description, now existing or hereafter arising under or pursuant to the terms of this Note, including, all interest, fees, charges, expenses, attorneys&#8217; fees and costs and accountants&#8217; fees and costs chargeable to and payable by the Company hereunder and thereunder, in each case, whether direct or indirect, absolute or contingent, due or to become due, and whether or not arising after the commencement of a proceeding under Title&#160;11 of the United States Code (11&#160;U. S. C. Section&#160;101 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.), as amended from time to time (including post-petition interest) and whether or not allowed or allowable as a claim in any such proceeding. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean and include an individual, a partnership, a corporation (including a business trust), a joint stock company, a limited liability company, an unincorporated association, a joint venture or other entity or a governmental authority.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Term SOFR Determination Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning assigned to it under the definition of Term SOFR Reference Rate.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Term SOFR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, for any tenor comparable to the applicable Interest Period, the Term SOFR Reference Rate at approximately 5&#58;00&#160;a.m., Chicago time, two U.S. Securities Business Days prior to the commencement of such tenor comparable to the applicable Interest Period, as such rate is published by the CME Term SOFR Administrator.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Term SOFR Reference Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, for any day and time (such day, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Term SOFR Determination Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), for any tenor comparable to the applicable Interest Period, the rate per annum reasonably determined by the Company as the forward-looking term rate based on SOFR. If by 5&#58;00&#160;p.m. (New York City time) on the fifth&#160;(5th) U.S. Government Securities Business Day immediately following any Term SOFR Determination Day, the &#8220;Term SOFR Reference Rate&#8221; for the applicable tenor has not been published by the CME Term SOFR Administrator, then the Term SOFR Reference Rate for such Term SOFR Determination Day will be the Term SOFR Reference Rate as published in respect of the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate was published by the CME Term SOFR Administrator.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">U.S. Government Securities Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any day except for (i)&#160;a Saturday, (ii)&#160;a Sunday or (iii)&#160;a day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United&#160;States government securities.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:27.75pt">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.8pt">Waiver and Amendment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any provision of this Note may be amended, waived or modified upon the written consent of the Company and Investor.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.18pt">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail (if to Investor) or otherwise delivered by hand, messenger or courier service addressed&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:115.63pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18pt">if to Investor, to Investor&#8217;s address, facsimile number or electronic mail address as shown in the Company&#8217;s records, as may be updated in accordance with the provisions hereof, or, until such holder so furnishes an address, facsimile number or electronic mail address to the Company, then to the address, facsimile number or electronic mail address of the last holder of this Note for which the Company has contact information in its records&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:112.58pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18pt">if to the Company, to the attention of the Chief Executive Officer or Chief Financial Officer of the Company at 3530&#160;John Hopkins Court, San&#160;Diego, CA 92121, or at such other current address as the Company shall have furnished to Investor, with a copy (which shall not constitute notice) to Martin J. Waters, Wilson Sonsini Goodrich&#160;&#38; Rosati, P.C., 12235&#160;El Camino Real, Suite&#160;200, San&#160;Diego, CA 92130-3002.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each such notice or other communication shall for all purposes of this Note be treated as effective or having been given (i)&#160;if delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service, freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), or (ii)&#160;if sent via mail, at the earlier of its receipt or five&#160;days after the same has been deposited in a regularly-maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid, or (iii)&#160;if sent via facsimile, upon confirmation of facsimile transfer or, if sent via electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent during normal business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient&#8217;s next business day. In the event of any conflict between the Company&#8217;s books and records and this Note or any notice delivered hereunder, the Company&#8217;s books and records will control absent fraud or error.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.8pt">Payment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Payments shall be made in lawful tender of the United States.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.18pt">Default Rate&#59; Usury.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> During any period prior to the Maturity Date in which a non-payment by the Company of the interest earned on any Advance has occurred and is continuing, or an Event of Default has occurred and is continuing, the Company shall pay interest on the unpaid principal balance hereof at a rate per annum equal to the rate otherwise applicable hereunder plus two&#160;percent (2%) per annum. In the event any interest is paid on any Advance which is deemed to be in excess of the then legal maximum rate, then that portion of the interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal and applied against the principal of the applicable Advance.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.8pt">Waivers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Company hereby waives notice of default, presentment or demand for payment, protest or notice of nonpayment or dishonor and all other notices or demands relative to this instrument.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:25.02pt">Governing Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> This Note and all actions arising out of or in connection with this Note shall be governed by and construed in accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California, or of any other state. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.18pt">Restriction on Transferability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> This Note and the rights and obligations hereunder may not be assigned by either the Investor or the Company without the prior written consent of the other party.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.18pt">Registration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company or its agent will keep books for the registration and registration of transfer of the Note. Subject to this section and any other restrictions on or conditions to transfer set forth in the Note, the Note may be transferred only upon its surrender to the Company for registration of transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer in form satisfactory to the Company. Prior to registration of any such transfer, the Company shall treat the person in whose name the Note is registered as the owner and holder of the Note for all purposes, including payment of principal and interest, and the Company shall not be affected by notice to the contrary.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-5-</font></div></div></div><div id="i66fd16c6e8854b2aba86c47dc4155d3f_61"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company has caused this Note to be issued as of the date first written above.</font></div><div style="margin-top:24pt;padding-left:252pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.153%"><tr><td style="width:1.0%"></td><td style="width:16.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">IMMUNITYBIO, INC.,</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a Delaware corporation</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Richard Adcock</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Richard Adcock</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Signature page for Note)</font></div></div></div><div id="i66fd16c6e8854b2aba86c47dc4155d3f_64"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:4pt;padding-right:-0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">SCHEDULE A</font></div><div style="margin-bottom:6pt;margin-top:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TO PROMISSORY NOTE</font></div><div style="margin-top:4pt;padding-right:-0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ADVANCES</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:19.1pt;padding-right:19.1pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date of Advance</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.07pt;padding-right:0.07pt;text-align:center;text-indent:-0.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Original Principal</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amount of Advance</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amount and Date(s) of </font></div><div style="padding-right:-1.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepayments of Advance</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:0.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding Principal Balance of Advance</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:19.15pt;padding-right:19.15pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"><div style="padding-left:19.15pt;padding-right:19.15pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Schedule A</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ibrx-20230613.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:dde078f5-98c7-47b5-ab32-a2774d4ecadd,g:827debd4-f8c9-486d-8cad-ec7a2a200e4d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ibrx="http://www.immunitybio.com/20230613" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.immunitybio.com/20230613">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ibrx-20230613_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ibrx-20230613_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.immunitybio.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ibrx-20230613_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:dde078f5-98c7-47b5-ab32-a2774d4ecadd,g:827debd4-f8c9-486d-8cad-ec7a2a200e4d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_e9e418fa-185f-4bf4-ac52-3a7bd1f3bf70_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5802ed96-be69-41bc-9cbc-32da7c978f8d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security 12b Title</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_96799cf8-d7c2-469f-bafb-f3d3189323d4_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2b8ef234-edad-4efa-81bb-fdbde18b442f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_442c4bba-62ed-4041-91ba-2133d3905aaa_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a2cff88c-525e-4491-a2b0-eb47817366ae_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_bef4bb8e-b193-4870-b565-32a33a78bc4d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d8a609dc-9930-4219-be03-0aa871aad66b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c71f5adc-69e2-4d49-bee7-bc4ba9ce3d1d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_288b2894-53ce-49e1-90cb-77701ef5805f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_01ab0a78-4a53-491d-9821-ee3d6b80a5f5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_3c943f51-0da6-435d-9f8e-78c10528b1bb_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_606398f7-4150-4b8d-9629-cdd34172fe56_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_16ae3129-f9ab-4d42-b930-3255cff1dedb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9a449432-c458-4cff-ac20-d3b53d0fde1e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8b0e57a1-540f-4ee5-9961-b7eae1494e7a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a359498f-d540-4b86-a6c6-125e2f75bb7d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5e56cbcc-d74a-4bc0-9d1b-b3af3605ee07_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a2c7129c-f359-4337-801f-ac4978325e24_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7db73716-6a74-4e47-8f02-d5702db7dff8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_cf2bc625-6d3b-4422-b0d4-7c9785cc4b5b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2d9073d6-8b9b-4c4c-a4eb-041604d3aaa3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_09adade3-c21c-4009-8bb1-30411e2ac866_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ibrx-20230613_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:dde078f5-98c7-47b5-ab32-a2774d4ecadd,g:827debd4-f8c9-486d-8cad-ec7a2a200e4d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.immunitybio.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="ibrx-20230613.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.immunitybio.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c3a6a879-5e9c-4f36-88ff-eefb73e8ce4b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_DocumentType_c3a6a879-5e9c-4f36-88ff-eefb73e8ce4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_1eb1a012-3743-4a63-ae75-337e79b4eccd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_DocumentPeriodEndDate_1eb1a012-3743-4a63-ae75-337e79b4eccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c7fb3d07-b9f6-44a9-acfe-c52621548fa1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityRegistrantName_c7fb3d07-b9f6-44a9-acfe-c52621548fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b0a88b40-9a83-4fde-b3e4-2ea1cb13ac01" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b0a88b40-9a83-4fde-b3e4-2ea1cb13ac01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1a251913-900d-4097-930b-3f608756619e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityFileNumber_1a251913-900d-4097-930b-3f608756619e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6b2fa6b9-7891-4cb3-aadf-d9d807176af3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityTaxIdentificationNumber_6b2fa6b9-7891-4cb3-aadf-d9d807176af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f16a743c-14ac-44b4-8af8-d403150ad72d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityAddressAddressLine1_f16a743c-14ac-44b4-8af8-d403150ad72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_6e7c695d-5278-4a9d-8da2-b4b8e1c54f54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityAddressCityOrTown_6e7c695d-5278-4a9d-8da2-b4b8e1c54f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d2e748f4-f9ab-4f7d-b51c-8d651e73e95c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityAddressStateOrProvince_d2e748f4-f9ab-4f7d-b51c-8d651e73e95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_50d9f069-3972-49bc-8f9e-12ba9e75799b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityAddressPostalZipCode_50d9f069-3972-49bc-8f9e-12ba9e75799b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ed5fd559-1d1d-42fd-8e36-cfa8608f7e19" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_CityAreaCode_ed5fd559-1d1d-42fd-8e36-cfa8608f7e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_937a2b91-1465-4b8c-9cf1-364bdeb471f8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_LocalPhoneNumber_937a2b91-1465-4b8c-9cf1-364bdeb471f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_d36af865-4cd0-445e-b1f7-a104cb28a396" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_WrittenCommunications_d36af865-4cd0-445e-b1f7-a104cb28a396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_391e4fa3-b455-41d8-b94f-96b7f02372a9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_SolicitingMaterial_391e4fa3-b455-41d8-b94f-96b7f02372a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_0a9ce74f-0618-4fd9-b9db-127b854247e5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_PreCommencementTenderOffer_0a9ce74f-0618-4fd9-b9db-127b854247e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_34230e42-085a-4d8a-ae82-a62d3b150f05" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_34230e42-085a-4d8a-ae82-a62d3b150f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a732a2e0-34d4-4043-9e25-72a2b6275024" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_Security12bTitle_a732a2e0-34d4-4043-9e25-72a2b6275024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7a5fbfe2-1dbd-493e-a075-b5411df72876" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_TradingSymbol_7a5fbfe2-1dbd-493e-a075-b5411df72876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f9488c91-c403-4e23-b558-796e97730e7c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_SecurityExchangeName_f9488c91-c403-4e23-b558-796e97730e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4ff97d84-1f41-4cef-943b-1fd8a8a75fdc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityEmergingGrowthCompany_4ff97d84-1f41-4cef-943b-1fd8a8a75fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6bcc4ecb-f3a8-41c0-bd3d-000bef3fc72a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_AmendmentFlag_6bcc4ecb-f3a8-41c0-bd3d-000bef3fc72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_14c31b59-20eb-461a-b164-80d69acbc16c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3d064530-9351-4983-a6e5-14d96cc7f158" xlink:to="loc_dei_EntityCentralIndexKey_14c31b59-20eb-461a-b164-80d69acbc16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140394860990656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 13,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ImmunityBio, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">43-1979754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3530 John Hopkins Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(844)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">696-5235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IBRX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>ibrx-20230613_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ibrx-20230613.xsd" xlink:type="simple"/>
    <context id="ic573696c5133416983acc6b174855433_D20230613-20230613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326110</identifier>
        </entity>
        <period>
            <startDate>2023-06-13</startDate>
            <endDate>2023-06-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN180L2ZyYWc6OTM0ZTk5MmNhZjhlNDA3N2IzZTc5MDMzYjA2ZWEyZjIvdGFibGU6NzU1MjZmYWQwODc0NDljYmE1MmJjNTk0ZWI0ZmI3YjYvdGFibGVyYW5nZTo3NTUyNmZhZDA4NzQ0OWNiYTUyYmM1OTRlYjRmYjdiNl8wLTEtMS0xLTMzOTY2MQ_de8c0ab4-ddc5-44a5-a99b-821ca7897ad0">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN180L2ZyYWc6OTM0ZTk5MmNhZjhlNDA3N2IzZTc5MDMzYjA2ZWEyZjIvdGFibGU6NzU1MjZmYWQwODc0NDljYmE1MmJjNTk0ZWI0ZmI3YjYvdGFibGVyYW5nZTo3NTUyNmZhZDA4NzQ0OWNiYTUyYmM1OTRlYjRmYjdiNl8xLTEtMS0xLTMzOTY2MQ_8e7fe26d-1fd2-4e21-a53d-52f5e58c33b3">0001326110</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzY5_6c530b40-5c37-4da0-84e1-7e669338456d">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8yMjc_bb0ce066-46ec-4f73-8ffa-ac08eb6f4d2f">2023-06-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzcz_446a7a89-a699-469b-b235-1a06f419da16">ImmunityBio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MGYyOGVhYmMyNWExNDg2M2IyMGQzMDBkMjY5OGI1M2UvdGFibGVyYW5nZTowZjI4ZWFiYzI1YTE0ODYzYjIwZDMwMGQyNjk4YjUzZV8wLTAtMS0xLTMzOTY2MQ_0cc12a1b-74b6-47fd-b4a3-6ac302b93acf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MGYyOGVhYmMyNWExNDg2M2IyMGQzMDBkMjY5OGI1M2UvdGFibGVyYW5nZTowZjI4ZWFiYzI1YTE0ODYzYjIwZDMwMGQyNjk4YjUzZV8wLTItMS0xLTMzOTY2MQ_87b545a6-a0af-4873-967f-b3a895c53d74">001-37507</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MGYyOGVhYmMyNWExNDg2M2IyMGQzMDBkMjY5OGI1M2UvdGFibGVyYW5nZTowZjI4ZWFiYzI1YTE0ODYzYjIwZDMwMGQyNjk4YjUzZV8wLTQtMS0xLTMzOTY2MQ_ea2f983a-4da4-4a96-a2e9-dfb6020483af">43-1979754</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzcw_8d05f952-47ed-4ac3-b856-3dd8bc6c29af">3530 John Hopkins Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzc0_17d93e49-9c4e-45a6-8f32-6dd9b1a2d104">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzc1_ca1ee43c-c9bb-472d-81f0-e126b64c28a5">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzcy_7da7af64-403c-4505-91c1-dd8ef62b841f">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzcx_9ed94189-5192-481b-a06c-20ff1465aafe">(844)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzY3_c168ec07-a023-44bf-a1dc-b04f69ee9d67">696-5235</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MDg4N2U4ZjUyMmE2NDU4Nzk3NTBjYzZlNjc2ZWMxZTAvdGFibGVyYW5nZTowODg3ZThmNTIyYTY0NTg3OTc1MGNjNmU2NzZlYzFlMF8wLTAtMS0xLTMzOTY2MQ_bd6be309-01f4-4953-9432-828ba93bd145">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MDg4N2U4ZjUyMmE2NDU4Nzk3NTBjYzZlNjc2ZWMxZTAvdGFibGVyYW5nZTowODg3ZThmNTIyYTY0NTg3OTc1MGNjNmU2NzZlYzFlMF8yLTAtMS0xLTMzOTY2MQ_c667dee1-22d9-4d11-a26f-6788c40abc5d">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MDg4N2U4ZjUyMmE2NDU4Nzk3NTBjYzZlNjc2ZWMxZTAvdGFibGVyYW5nZTowODg3ZThmNTIyYTY0NTg3OTc1MGNjNmU2NzZlYzFlMF80LTAtMS0xLTMzOTY2MQ_af7f9738-5b0a-455e-b5fe-0044afba8268">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6MDg4N2U4ZjUyMmE2NDU4Nzk3NTBjYzZlNjc2ZWMxZTAvdGFibGVyYW5nZTowODg3ZThmNTIyYTY0NTg3OTc1MGNjNmU2NzZlYzFlMF82LTAtMS0xLTMzOTY2MQ_38a898e7-9d24-4b79-85a1-ecb608534cf9">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6YmQ4ZmRjNzQ5YzRkNGRiNmI5NWQxNGYyMzlmNmM1ZDUvdGFibGVyYW5nZTpiZDhmZGM3NDljNGQ0ZGI2Yjk1ZDE0ZjIzOWY2YzVkNV8xLTAtMS0xLTMzOTY2MQ_1728ef78-1f39-4741-85e3-5e7638db61f4">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6YmQ4ZmRjNzQ5YzRkNGRiNmI5NWQxNGYyMzlmNmM1ZDUvdGFibGVyYW5nZTpiZDhmZGM3NDljNGQ0ZGI2Yjk1ZDE0ZjIzOWY2YzVkNV8xLTItMS0xLTMzOTY2MQ_d58597b0-782f-494d-93a0-6a8377283edb">IBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGFibGU6YmQ4ZmRjNzQ5YzRkNGRiNmI5NWQxNGYyMzlmNmM1ZDUvdGFibGVyYW5nZTpiZDhmZGM3NDljNGQ0ZGI2Yjk1ZDE0ZjIzOWY2YzVkNV8xLTQtMS0xLTMzOTY2MQ_a83e864a-9be1-44b1-862e-24e235ae235b">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic573696c5133416983acc6b174855433_D20230613-20230613"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0NzUyMjQ3ZjZlMjQzMzlhZjNiYmFlODFjMjk0YjI3L3NlYzpkNDc1MjI0N2Y2ZTI0MzM5YWYzYmJhZTgxYzI5NGIyN18xL2ZyYWc6ZWY2NTYwODU1OGNmNGUxZTg3YzVmMDhiNDc4NzRkZjQvdGV4dHJlZ2lvbjplZjY1NjA4NTU4Y2Y0ZTFlODdjNWYwOGI0Nzg3NGRmNF8xMzY4_329896f0-1120-4de7-9de2-75254321f57b">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ..)SE8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #CB<Y6"K  @N\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>NFG9#E&7"]-.("$Q"<0M2KPMHFFBQ*C=V].&K1."!^ 8^\_G
MSY);'83V$9^C#QC)8KH;7=<GH<.&G8B" $CZA$ZE<DKT4_/@HU,T/>,1@M(?
MZHA05]4:')(RBA3,P"(L1"9;HX6.J,C'"][H!1\^8Y=A1@-VZ+"G!+SDP.0\
M,9S'KH4;8(811I>^"V@68J[^B<T=8)?DF.R2&H:A')J<FW;@\/;T^)+7+6R?
M2/4:IU_)"CH'W+#KY-?F8;O?,5E7=5-4ZX+?[VLN^$I4J_?9]8??3=AY8P_V
M'QM?!64+O^Y"?@%02P,$%     @ XXG.5IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MBS&<PM[H- HN\/-UM_L+AE*O!SYNXY]D"%%9Q%)@WM$BTA_V+WM!IX<1U<N
MC_OW5\6-80)"4QAYZ1RZD0H76M-$,PRI=G\?=^FE3'C(#1<;\AD27'&:-/+@
M*JT\M=_[N%DO%"O"PV"&E5L*)B+8_'Q9KT^,'Z[72E8[OX\;]3=D<ZUS(&L%
MQ&5; 6OO]W&K7K(P5W;Z^<&*/'.3-$\_7,3VL-@ R/#E@F14D2U-<D9^]*X\
M6$A)!EW5,548<E"O  %NV<^*1C;UEOMT)1L3KT5@?OOT)T92VWV 6W,5O/O7
M,*9BPTYNT5J$'J?+N^EO&-/1KO\LG[]/F=K8*+T#!1/;),RHV#>RX8)MN1;4
M-A_@+CV%&1 5L^ AH9M&%%R@%:6V^0!WZ$.49@"CP._G,!M?R4?6'!]<RF9X
M)^C[OM=$YAZ=,.UI_3.UPZ))PM:@YET-P+-5>0 N"T9FQ:%S)0T<88O;F%$P
M"UL!WJ^E-&\%>XZM_H:8_ =02P,$%     @ XXG.5I^@&_"Q @  X@P   T
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ XXG.5@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #C
MB<Y6"K  @N\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " #CB<Y6F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ..)SE;3LP+%
M2 0  )(0   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " #CB<Y6GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"  #L$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ibrx-20230613.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.immunitybio.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ibrx-20230613.htm">ibrx-20230613.htm</File>
    <File>ibrx-20230613.xsd</File>
    <File>ibrx-20230613_lab.xml</File>
    <File>ibrx-20230613_pre.xml</File>
    <File>ibrx-2023613x8kexhibit101.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ibrx-20230613.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ibrx-20230613.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ibrx-20230613_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ibrx-20230613_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ibrx-20230613.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ibrx",
   "nsuri": "http://www.immunitybio.com/20230613",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ibrx-20230613.htm",
      "contextRef": "ic573696c5133416983acc6b174855433_D20230613-20230613",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.immunitybio.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ibrx-20230613.htm",
      "contextRef": "ic573696c5133416983acc6b174855433_D20230613-20230613",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.immunitybio.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001326110-23-000076-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001326110-23-000076-xbrl.zip
M4$L#!!0    ( ..)SE;:8-UW2!X  %7N   1    :6)R>"TR,#(S,#8Q,RYH
M=&WM7>M7VTBR_[Y_15]V=B\YQS)Z/TS"/00#ZUEL$G#"V%]R6E(+R^CAD63
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MFMQU6D^J>4U?: :P]X*<QC"+ISUH^QSH-TQ^!:M,LS0*>=FQ*K^*H21$2$<
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MQ0"WV5:%W7'QG?=!<-@?!(XQRDZ)D/-FT[KJ/^557S8K&FVBA27":H[2>!Q
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M_VK, Q@5!O!1)('O3,_P)V1>EB1HBJ018,HTI9Y=X3F?D:'R&(;&$S^),^S
M+&W(E526^'(OQ5G#N$.8 #ST^4PQ08J93U#F;"8XO=K9:^NY8ILZZ\#\%L $
MS7#>]OA" ]#Y]*% 3)O?%#P]M"#3$0WH>4DF_&+#\&%$WV@6H)!+$V;@3M,(
MM0)>?B;H"]O&K!K6$$B]Q$VYI==Q+#R!Z]:_[30=89)$)_UK)8_M"4^S!&1
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M(W\&_XS32?#N_P%02P$"% ,4    " #CB<Y6VF#==T@>  !5[@  $0
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(   B4@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
